A Review on Pharmacology of Combined Edaravone and Argatroban Therapy in Acute Ischemic Stroke

  • Posted on: 1 November 2014
  • By: admin

Pharma Admission

Pharma courses

pharma admission

pharma courses



Magazine Home


NOV 2014 ARTICLE LIST >>

PharmaTutor (November- 2014)

 

ISSN: 2347 - 7881
(Volume 2, Issue 11)

 

Received On: 26/08/2014; Accepted On: 07/09/2014; Published On: 01/11/2014

 

AUTHORS: Patel  Divya A*., Varodiya Priyanka S., Raj Hasumati A.
Department of Quality Assurance, Shree Dhanvantary Pharmacy College,
Kim, Surat, Gujarat, India
divyapatel388@gmail.com, drharaj@yahoo.com

 

ABSTRACT:
This review article presents the pharmacology of combined edaravone and argatroban therapy especially in acute ischemic stroke. Edaravone (MCI-186) is a free radical scavenger, a novel neuroprotective agent. Argatroban  is a selective thrombin inhibitor. The antithrombotic agent was used in acute cerebral infarction. If the antithrombotic agent is administered in large quantities, the condition of patient become worse by occurrence of adeverse effect of cerebral haeorrhage. The use of edaravone in combination with antithrombotic agent has been proved to provide beneficial effect in acute ischemic stroke as edaravone has no influence to coagulation of blood and platelets aggregation. The combination therapy has fewer hemorrhagic  adeverse  effect. The mechanism of argatroban and edaravone is quite different. Argatroban, an anti-coagulant drug, directly improves the microcirculation of ischemic brain tissue while edaravone could indirectly attenuated brain edema by protection of endothelial cells damaged by free radicals generated after ischemic insult. The combination of both would have reciprocal and enhanced neuroprotective effects against ischemic insult. Both the drugs were approved by Japanese government and has been used in acute brain infarction in japan. The main objective of this review article is to provide pharmacological information of combined therapy of edaravone and argatroban to researcher in development of combined dosage form of this.

 

How to cite this article: DA Patel, PS Varodiya, R Hasumati; A Review on Pharmacology of Combined Edaravone and Argatroban Therapy in Acute Ischemic Stroke; PharmaTutor; 2014; 2(11); 42-49

 

[ABSTRACT WITH CITATION]   [VIEW AS HTML]